Rate of Corticosteroid-Induced Mood Changes in Patients with Inflammatory Bowel Disease: A Prospective Study
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Corticosteroid is an effective therapeutic option for inflammatory bowel disease flares, but its adverse effects may compromise treatment adherence and reduce patients' quality of life. There is lack of data on the incidence of corticosteroid-induced mood changes in this patient population, which may be underappreciated by healthcare providers in clinical practice and interfere with optimal care. This study aimed to determine the rate of mood changes in this patient population. METHODS: In this prospective observational study, adult outpatients treated with prednisone for inflammatory bowel disease flares were considered for inclusion. Participants completed validated questionnaires (Beck Depression Inventory-II and Activation Subscale of Internal State Scale version two) before starting prednisone, after two weeks of prednisone, and at the end of prednisone taper to assess for mood changes. Harvey-Bradshaw Index and Simple Clinical Colitis Activity Index were used to monitor clinical disease activity. RESULTS: Fifty-three subjects were included in the analyses. The rate of mood change after two weeks of prednisone was 49.1%, primarily driven by increase in mood towards (hypo)mania. Younger age was an independent risk factor. Mood state returned to pretreatment level at the end of treatment. There was no correlation between clinical disease activity change and mood change. CONCLUSIONS: Oral prednisone for inflammatory bowel disease flare is associated with high rate of mood change. As prednisone is a critical part of induction therapy, ways to minimize this adverse event must be studied. For now, healthcare providers should inform patients and monitor closely for this adverse event.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Corticosteroid medications used in the care of IBD, such as prednisone, have well-known mood disturbance effects (17).”
From The 2023 Impact of Inflammatory Bowel Disease in Canada: Mental Health and Inflammatory Bowel Disease (2023) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients
Beck, A. T., Steer, R. A., Ball, R., & Ranieri, W. F. (1996) · Journal of Personality Assessment · doi:10.1207/s15327752jpa6703_13 · Cited by 5,965 · cited 2×
“Depressive symptoms were assessed using the Beck Depression Inventory II (BDI-II), a 21-item multiple choice questionnaire that asks participants to rate their symptoms such as sadness, loss of interest, guilt, agitation, suicidality, concentration and fatigue within the past two weeks (25).”
Sandborn, W. J., Feagan, B. G., Hanauer, S. B., Lochs, H., Löfberg, R., Modigliani, R., Present, D. H., Rutgeerts, P., Schölmerich, J., Stange, E. F., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.31072 · Cited by 686 · cited 1×
“correlation with Crohn’s Disease Activity index, which has been utilized extensively in previous Crohn’s disease trials (37).”
Glucocorticoid therapy in giant cell arteritis: Duration and adverse outcomes
Proven, A., Gabriel, S. E., Orces, C., O'Fallon, W. M., & Hunder, G. G. (2003) · Arthritis Care & Research · doi:10.1002/art.11388 · Cited by 612
A Comparison of Budesonide with Prednisolone for Active Crohn's Disease
Rutgeerts, P., Lofberg, R., Malchow, H., Lamers, C., Olaison, G., Jewell, D., Danielsson, A., Goebell, H., Thomsen, O. O., Lorenz-Meyer, H., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409293311304 · Cited by 589
Steroid-induced psychiatric syndromes
Lewis, D. A., & Smith, R. E. (1983) · Journal of Affective Disorders · doi:10.1016/0165-0327(83)90022-8 · Cited by 528 · cited 3×
“In contrast, higher incidence of CIMC in females was observed in earlier studies, but the interpretation was confounded by female predominance in certain autoimmune conditions such as rheumatoid arthritis and systemic lupus erythematosus (28, 39, 40).”
Jones, J., Loftus, E. V., Panaccione, R., Chen, L., Peterson, S., Mcconnell, J., Baudhuin, L., Hanson, K., Feagan, B. G., Harmsen, S. W., et al. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.06.010 · Cited by 414 · cited 1×
“Although HBI does not correlate well with endoscopic inflammation or fecal inflammatory marker (36, 38), use of such clinical disease activity index is warranted in absence of an objective modality that can accurately assess all phenotypes of Crohn’s disease.”
Bressler, B., Marshall, J. K., Bernstein, C. N., Bitton, A., Jones, J., Leontiadis, G. I., Panaccione, R., Steinhart, A. H., Tse, F., Feagan, B., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.001 · Cited by 413
Self-citationSide Effects of Corticosteroid Therapy: Psychiatric Aspects
Ling, M. H. M. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780290105011 · Cited by 342
Oral budesonide is as effective as oral prednisolone in active Crohn’s disease
Campieri, M., Ferguson, A., Doe, W., Persson, T., Nilsson, L.-G., & the Global Budesonide Study Group (1997) · Gut · doi:10.1136/gut.41.2.209 · Cited by 324
Dassopoulos, T., Sultan, S., Falck–Ytter, Y. T., Inadomi, J. M., & Hanauer, S. B. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.10.046 · Cited by 297
Cited by
Treatment of Inflammatory Bowel Disease: A Comprehensive Review
Cai, Z., Wang, S., & Li, J. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.765474 · Cited by 675
Borah, P., Deb, P. K., Chandrasekaran, B., Goyal, M., Bansal, M., Hussain, S., Shinu, P., Venugopala, K. N., Al‐Shar’i, N. A., Deka, S., et al. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.627723 · Cited by 57
“A previous Frontiers in Molecular Biosciences | www.frontiersin.org February 2021 | Volume 8 | Article 6277235 study suggests that acute necrotizing encephalopathy may occur due to the cytokine-mediated inflammations (Ouattara et al., 2011).”
BackgroundGhasemiyeh, P., Borhani‐Haghighi, A., Karimzadeh, I., Mohammadi‐Samani, S., Vazin, A., Safari, A., & Qureshi, A. I. (2020) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s259152 · Cited by 58
“Anxiety and Agitation Corticosteroid consumption could induce mood changes such as anxiety, agitation, and depression.(64) Generalized anxiety disorder, agitation, and depression are common post-stroke complications.”
BackgroundGraff, L. A., Geist, R., Kuenzig, M. E., Benchimol, E. I., Kaplan, G. G., Windsor, J. W., Bitton, A., Coward, S., Jones, J. L., Lee, K., et al. (2023) · Journal of the Canadian Association of Gastroenterology · doi:10.1093/jcag/gwad012 · Cited by 30
“Corticosteroid medications used in the care of IBD, such as prednisone, have well-known mood disturbance effects (17).”
BackgroundInflammatory Bowel Disease and Patients With Mental Disorders: What Do We Know?
Fousekis, F. S., Katsanos, A. H., Kourtis, G., Saridi, M., Albani, E., Katsanos, K. H., & Christodoulou, D. K. (2021) · Journal of Clinical Medicine Research · doi:10.14740/jocmr4593 · Cited by 28
Metadata
- Authors
- Ou, G., Bressler, B., Galorport, C., Lam, E., Ko, H. H., Enns, R., Telford, J., Schaffer, N., Lee, T., & Rosenfeld, G.
- Affiliations
- University of British Columbia (CA)
- Corresponding author
- Rosenfeld, Greg
- ORCID
- Venue
- Journal of the Canadian Association of Gastroenterology
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-06-04
- Volume
- 1
- Issue
- 3
- Pages
- 99-106
- ISSN
- 2515-2084 (ISSN-L)
- 2515-2092
- PMC
- PMC6507281
- OpenAlex
- W2807141938
- Cited by
- 28
- References
- 45
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 4 · 2023: 2 · 2022: 5 · 2021: 4 · 2020: 4 · 2019: 2 · 2018: 2
- FWCI
- 1.84
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of the Canadian Association of Gastroenterology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Canadian Association of Gastroenterology
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- prednisone, depression, hypomania, glucocorticoid adverse effects, age as risk factor, disease activity, induction therapy, mood tracking
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Rate of Corticosteroid-Induced Mood Changes in Patients with Inflammatory Bowel Disease: A Prospective Study. https://app.cochat.ai/papers/10.1093/jcag/gwy023
- The paper
- Ou, G., Bressler, B., Galorport, C., Lam, E., Ko, H. H., Enns, R., Telford, J., Schaffer, N., Lee, T., & Rosenfeld, G. (2018). Rate of Corticosteroid-Induced Mood Changes in Patients with Inflammatory Bowel Disease: A Prospective Study. Journal of the Canadian Association of Gastroenterology. https://doi.org/10.1093/jcag/gwy023
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

